John H. Lohrey

Oncology
400 W Magnolia Ave
Fort Worth, TX 76104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Domvanalimab plus zimberelimab in unresectable and immunotherapy refractory biliary tract cancers: a phase 2 trial.

Domvanalimab plus zimberelimab in unresectable and immunotherapy refractory biliary tract cancers: a phase 2 trial.

Journal: Nature communications
Published: December 16, 2025
Showing 1-1 of 1

Last Updated: 09/26/2026